• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

March 12, 2019

Tech Letter

Mad Hedge Technology Letter
March 12, 2019
Fiat Lux

Featured Trade:

(FIREEYE’S LAST LINE OF DEFENSE),
(FEYE), (MSFT), (AMZN), (GOOGL), (ORCL), (EFX), (IBM)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-12 01:07:242019-03-13 01:34:20March 12, 2019
Mad Hedge Fund Trader

FireEye’s Last Line of Defense

Tech Letter

A potential cataclysmic threat potentially wreaking havoc to our financial system is no other than cybercrime – that is one of the few gems that Fed Chair Jerome Powell delivered to the American public in a historic interview with 60 Minutes this past weekend.

Powell has even gone on record before claiming that Congress should do “as much as possible (against cybercrime), and then double it.”

The Fed Chair clearly has intelligence that retail investors wish they could get their hands on.

Digital nefarious attacks have been all the rage resulting in public blowups at Equifax (EFX) and North Korea’s state-sponsored hack on International Business Machines Corporation (IBM) just to name a few.

At the bare minimum, this means that cybersecurity solution companies will be the recipients of a gloriously expanding addressable market.

Powell’s testimony to the public was timely as it provides the impetus for investors to look at cybersecurity firms that will actively forge ahead and protect domestic business from these lurking threats.

Considering a long-term investment in FireEye Inc. (FEYE) at these beaten down prices could unearth value.

For all the digital novices, FireEye offers cybersecurity solutions allowing organizations to pre-emptively plan, prevent, respond to, and remediate cyber-attacks.

It offers vector-specific appliance, virtual appliance, and a smorgasbord of cloud-based solutions to detect and thwart indistinguishable cyber-attacks.

The company deploys threat detection and preventative methods including network security products, email security solutions, and endpoint security solutions.

And when you marry this up with my 2019 underlying thesis of the year of the enterprise software subscription, this company is on the verge of a breakout.

Last year was a year full of milestones for the company with the firm achieving non-GAAP profitability for the full year for the first time and generating positive operating and free cash flow for the full year.

The company was able to attract new business by adding over 1,100 new customers.

The cloud is where the company is betting all their chips and crafting the optimal subscription-as-a-service (SaaS) product is the engine that will propel the company’s shares higher.

The heart of their cloud initiative relies on Helix - a comprehensive detection and response platform designed to simplify, integrate and automate security operations.

This intelligence-led approach fuses innovative security technologies, nation-grade FireEye Threat Intelligence and world-renowned expertise from FireEye Mandiant into FireEye Helix.

By enhancing the endpoint products and email protection, sales of both products exploded higher by double digits YOY as FireEye successfully displaced incumbent vendors and legacy technology to the delight of shareholders.

As a result, the firm’s pipeline of opportunities continues to build.

As for network security, FireEye plans to extend the reach of their market-leading advanced threat protection capabilities further into the cloud with protection specifically aimed for cloud heavyweights Microsoft (MSFT) Azure, Amazon Web Services (AWS), Google (GOOGL) and Oracle (ORCL) Cloud.

They are collaborating with these major cloud providers on hybrid solutions that integrate seamlessly with their technologies so FireEye solutions will easily snap into a customer's cloud deployments.

Cloud subscriptions and managed services were the ultimate breakout performer highlighting the successful outsized pivot to (SaaS) revenue.

This segment increased 31% sequentially and 12% YOY, highlighting underlined strength in the segments of managed defense, standalone threat intelligence, Helix subscriptions, and cloud email solution.

The furious growth was achieved even though Q4 2017 billings included a $10 million plus transaction and if this deal is excluded, cloud subscriptions and managed services would have grown more than 30% YOY in Q4 2017 demonstrating the hard bias to the cloud has been highly instrumental to its success.

Recurring billings expanded 12% YOY, a small bump in acceleration from 11% in Q3, but if you remove that big deal in Q4 '17, recurring billings grew over 20% YOY in Q4 2018.

The growing chorus of product satisfaction can be found in the customer retention rate of 90%.

Transaction volume was at record levels for both deals greater than $1 million and transactions less than $1 million, signaling not only that customer renewals are expanding, but also explosion of new revenue streams captured by FireEye is aiding the top line.

This story is all about the recurring revenue and I expect that narrative to perpetuate throughout 2019 as an overarching theme to the strength of the firm’s revenue drivers.

The 10% billings growth last quarter paints a more honest trajectory of the true growth proposition for FireEye.

I believe the 6%-to-7% revenue guide for fiscal 2019 is down to the accounting technicals manifesting in the appliance revenue that is fading from the overall story.

The solid billings growth underpinning the overall business meshing with diligent expense control is conjuring up a massive amount of operating leverage.

Shares are undervalued and offer an attractive risk versus reward proposition.

If the company delivers on its core growth outlook, which I fully expect them to do plus more, shares should climb over $20 barring any broad-based market meltdowns.

I am bullish FireEye and urge readers to wait for shares to settle before putting new money to work.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2019/03/billings-growth.png 708 974 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-12 01:06:142019-07-10 21:43:40FireEye’s Last Line of Defense
Mad Hedge Fund Trader

March 13, 2019 - Quote of the Day

Tech Letter

“It takes 20 years to build a reputation and few minutes of cyber-incident to ruin it.” Said Global Chief Information Security Officer at Société Générale International Banking Stéphane Nappo

https://www.madhedgefundtrader.com/wp-content/uploads/2019/03/nappo.png 331 247 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-12 01:05:242019-07-10 21:43:47March 13, 2019 - Quote of the Day
Mad Hedge Fund Trader

March 11, 2019

Tech Letter

Mad Hedge Technology Letter
March 11, 2019
Fiat Lux

Featured Trade:

(THE BEST TECH PLAY IN HEALTHCARE),
(ISRG), (GOOGL), (JNJ)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-11 04:07:282019-07-10 21:43:54March 11, 2019
Mad Hedge Fund Trader

The Best Tech Play in Healthcare

Tech Letter

Seeking for a great long-term buy and hold tech name?

Then look no further than Intuitive Surgical, Inc. (ISRG).

Intuitive Surgical develops and produces robotic products designed to enhance clinical outcomes for patients through minimally invasive surgery, its most well-known product is the da Vinci surgical system.

Healthcare is one sector that I have rarely touched on, but not only will this cross-pollination with tech serve a social good, investors have a chance to rake in future profits.

The da Vinci systems and Intuitive Surgical are the best of breed and have had almost zero competition in the past 20 years.

The systems are placed in operating room used for invasive surgery for various types of ailments from cancer to hernia, and the systems were successfully used over one million times for surgery last year.

The da Vinci systems aren’t cheap – they cost $1.5 million and the customers, usually the hospitals, buy the add-ons of extra parts and supplies that inflate the price another $1,900.

As you would expect, net profit margins are compelling, being over 30% which e-commerce companies would give a left leg for translating into numbers that make the company incredibly profitable.

The story of the da Vinci systems starts way back in the 80s with the Defense Advanced Research Projects Agency (DARPA) hoping it could figure out how to offer surgeons the ability to operate remotely on soldiers wounded on the battlefield.

SRI International (SRI), an American nonprofit scientific research institute and organization took the painstaking time to develop the technology.

SRI's intellectual property was eventually acquired in 1994 and incorporated a new company named Intuitive Surgical Devices by the founders.

It took another 4 years for the FDA (Food and Drug Administration) to finally approve usage of the da Vinci Surgical System.

The first available surgery was for general laparoscopic surgery used to address gallbladder disease and gastroesophageal disease.

The next year saw another harvest of approvals with the FDA giving the green light to use the system for prostate surgery.

The approvals started to flow like a waterfall with thoracoscopic surgery, cardiac procedures performed with adjunctive incisions, and gynecologic procedures also approved by the FDA.

Fast forward to 2019 and the company couldn’t be financially healthier looking back at the year of 2018 in review.

Instruments & Accessories revenues came in at $1.96 billion comprising 52.7% of total revenue.

System sales crushed it with $1.13 billion, growth of 30.3% YOY and service sales amounted to $635.1 million up 17% YOY.

And in the latest quarter, Intuitive Surgical reported 19% YOY growth in worldwide da Vinci procedure volumes which contributed to bumping up revenue 18% YOY in the instruments and accessories segment.

The company is seeing the same type of success abroad with foreign revenues totaling $307 million, up 24% YOY.

Intuitive Surgical installed 115 systems in the previous quarter outside of America compared with 86 in the quarter before last.

55  of these new systems were installed in Europe, 31 in Japan, and nine in Brazil.

Procedure growth is forecasted to expand between 13-17%, fueled by U.S. general surgery and procedures.

Unfortunately, the stock sold off after earnings because adjusted operating expenses are expected to rise 20-28% reminding investors that the stock can’t always move up in a straight line.

The harm to operating margins is a tough pill to swallow in the short-term, but that does not take away the gloss from this leading tech company.

Intuitive Surgical plans to branch out from the da Vinci systems with its new Ion system, a robotic-assisted bronchoscope awaiting FDA clearance, a revolutionary way to kill cancer cells inside the lung.

After decades of unbridled market leadership, there are a few icebergs ahead in the distance in the form of competition.

Verb Surgical, a collaboration between Johnson & Johnson (JNJ) and Alphabet (GOOGL), will enter the healthcare robot surgery market in 2020.

Johnson & Johnson recently indicated it will splurge $3.4 billion in cash for Auris Health, a robotics startup with a device to perform lung biopsies that could compete with Intuitive Surgical’s Ion system.

Auris Health was approved by the FDA in March 2018 for this device that performs lung biopsies and Intuitive Surgical promptly sued citing patent infringement.

Auris Health was established by the co-founder of Intuitive Surgical Dr. Frederic Moll who pioneered the field of surgical robotics but left Intuitive in 2003 after 8 years there.

Intuitive could rub up on some more competition in the future, that is a stark possibility, but the pathway to profits are still open as the company rolls out different systems, services, and has the capital to fund new directions.

Hospitals that already have existing relationships with Intuitive will be less inclined to switch over to competing services if they are satisfied with the quality, service, and price points of the equipment.

This will help Intuitive build on the current strong momentum and ensure their products are in the pipeline to be adopted by the next batch of future demand.

Shares of the company are sky-high and expensive with a PE multiple of 55.

The big investment into R&D is in no doubt to fend off the potential competition around the corner, but I view that as a net positive.

It would be logical to wait for a pullback to buy shares, this one is a keeper.

https://www.madhedgefundtrader.com/wp-content/uploads/2019/03/da-vinci-e1552290991511.png 289 580 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-11 04:06:502019-07-10 21:44:00The Best Tech Play in Healthcare
Mad Hedge Fund Trader

March 11, 2019 - Quote of the Day

Tech Letter

“We think coding should be required in every school because it's as important as any kind of second language.” – Said CEO of Apple Tim Cook

https://www.madhedgefundtrader.com/wp-content/uploads/2018/04/Tim-cook-e1522704844602.jpg 374 300 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-11 04:05:012019-07-10 21:44:06March 11, 2019 - Quote of the Day
Mad Hedge Fund Trader

March 7, 2019

Tech Letter

Mad Hedge Technology Letter
March 7, 2019
Fiat Lux

Featured Trade:

(WILL NIO EAT TESLA’S LUNCH?),
(TSLA), (XPENG), (NIO)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-07 02:07:482019-07-10 21:44:12March 7, 2019
Mad Hedge Fund Trader

Will NIO Eat Tesla's Lunch

Tech Letter

The death of Tesla.

There is a sudden existential threat for one of the transformational American companies of the century created by Elon Musk.

And you can thank China for it.

If you didn’t know it, there are over 500 electric vehicle (EV) firms in China and the most widely known is NIO Inc.

NIO’s production chain spans just 20% the size of Tesla and has only delivered just a few thousand cars to this point.

Part of the reasoning for Tesla’s Musk to roll out a cheaper version of the Model 3 sedan was in reaction to the potential pipeline of China manufactured EV cars coming online.

The mushrooming of the electric car industry in China could be a death knell for Tesla.

Not only is the company battling stand-alone Chinese companies now for market share, but they will need to overcome the support of the Chinese communist party and the unlimited funds they throw at these types of national initiatives through generous subsidies.

As we speak, the communist party is starting to consolidate the national automotive industry and China’s National Development and Reform Commission will pour resources into the certain firms they believe can become national EV champions.

As it stands, China's sold more than 1 million electric vehicles in 2018 and could sell 2 million EVs by 2020.

And by 2030, China could dominate the global EV market by snatching 50% of the market.

I believe Tesla has absolutely zero future in China because of the explicit fact they are not a Chinese company and at this stage of the game, China and its home-grown tech are comfortable enough to stand behind the quality of their tech no matter how they acquire the secrets.

In fact, NIO Inc. produced an EV car that is above average quality and will improve with each iteration.

Headaches have already started to compile for Tesla as well when 1,171 Model 3 sedans arrived at industrial city Tianjin and were duly blocked with customs unhappy with the sticker labeling.

This nitpicking is a warning sign for things to come and Tesla will be hard-pressed to become what Apple was in China before Chinese consumers stopped buying iPhones. Or it may be just another iteration of the trade war, now a year old.

Don’t forget that US imported automobiles are exposed to high 100% customs duties that were infamously present even before the trade war began.

A Tesla factory in Shanghai is in the works with the $2 billion loan coming from a state-owned Chinese bank which vanishes any in-house knowhow Tesla planned to keep under wraps.

American high-end products will have to take on a bevy of domestic competitors, even some that possess borrowed foreign technology.

Along with the headwinds of battling state subsidies, Tesla will have to grapple with the price points at which Chinese EV companies sell their cars.

NIO’s ES6 is the follow up to the first all-electric SUV called the ES8 and deliveries start in June.

The car will go on sale for 358,000 RMB, or about $51,000, and that’s before government subsidies.

The 70kWh battery pack offers 254 miles of range and mimics Tesla features with an 11.3-inch touchscreen.

And if you thought Tesla could absorb the heavy blow from a $51,000 price point before government subsidies, then there is burgeoning EV firm Xpeng that crashes the price points even further.

The founder of Xpeng, Henry Xia, has conceded publicly that he was deeply influenced by Tesla and admitted his company was open-sourcing their patents.

The Xpeng G3 starts at 227,800 RMB, equivalent to less than $33,000, once again, before any government subsidies.

The product copies Tesla-style touchscreen features on the dashboard and has battery range capabilities of around 230 miles.

And here is the game changer, the effect of government subsidies could crater the price of these two types of Chinese EV cars to less than $9,000 for the consumer.

Game over for Tesla.

I surmise that once these Chinese EV cars cross the threshold of quality that puts the Chinese variant close to 75% as good as Tesla’s version, potential customers will flock to cheaper Chinese EV firms will a deluge of mass orders.

The global EV industry is the next high-tech industry to get hijacked from the Americans by the industrious Chinese who collaborate with state financial power to take down foreign competition.

Tesla, its leader Elon Musk, and every other high-end German car company are facing down a barrel of a gun that will prove to be an existential crisis of epic proportions.

This is all part and parcel of China’s plan to reshape the global export value chain.

China’s response is to crash the price of EV’s and use state support to outlast external competitors.

Equally as important, China has a massive shortage of EV infrastructure posing problems for Tesla cars to charge up outside.

This could be the trick up the sleeve of Beijing, they could easily squeeze Tesla out of the mix by allowing only home-grown EV cars to charge up at public charging stations citing security concerns of American technology.

The effect would be that Tesla owners would only be able to fill up in the confines of their own house which is problematic since most urban Chinese who can afford Teslas live in skyrise apartments without a personal garage.

The Middle Kingdom is also facing an ecological crisis at home and an exaggerated migration to EV cars is the state’s solution to cleaning up the domestic environment.

The long-term vision appears to have no place for Tesla in the Chinese economy – they already have their own Tesla’s and more imitations in the pipeline hoping to crash the price points even further.

Even more frustrating, 2020 or 2021 is the timeline to get Tesla production up and running in Shanghai, but by then, Tesla and Musk might be fighting from a position of weakness.

 

 

XPENG G3 FOR LESS THAN $33,000

https://www.madhedgefundtrader.com/wp-content/uploads/2019/03/xpeng.png 522 800 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-07 02:06:152019-03-07 01:41:52Will NIO Eat Tesla's Lunch
Mad Hedge Fund Trader

March 7, 2019 - Quote of the Day

Tech Letter

“Some people don't like change, but you need to embrace change if the alternative is disaster.” – Said Founder and CEO of Tesla Elon Musk

https://www.madhedgefundtrader.com/wp-content/uploads/2018/08/Elon-Musk-quote-of-the-day-e1534795386500.jpg 429 300 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-07 02:05:352019-07-10 21:44:23March 7, 2019 - Quote of the Day
Mad Hedge Fund Trader

March 6, 2019

Tech Letter

Mad Hedge Technology Letter
March 6, 2019
Fiat Lux

Featured Trade:

(BUY SALESFORCE ON THE DIP),
(CRM)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2019-03-06 10:12:312019-07-10 21:44:29March 6, 2019
Page 256 of 312«‹254255256257258›»

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top